Early surfactant therapy guided by lung ultrasound for very preterm infants
Part of Lungs & breathing clinical trials.
This trial tests whether giving a lung treatment (pulmonary surfactant) earlier, based on ultrasound scores, helps very preterm babies (born before 32 weeks) with breathing problems. It aims to improve their outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born before 32 weeks of pregnancy.
- Your baby must have trouble breathing after birth, like fast breathing or grunting.
- Your baby must be born at the hospital running this study.
- Your baby cannot have already received surfactant treatment before joining the trial.
- Your baby must not have any major birth defects, especially of the heart or lungs.
- Your baby must not have severe complications at birth, like severe infection or collapsed lung.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a lung medication called pulmonary surfactant, given with different oxygen levels, to help very premature babies (born before 32 weeks) who have breathing difficulties. The goal is to see which oxygen level works best with non-invasive breathing support.
This trial uses a lung ultrasound score, a type of ultrasound, to decide when to give surfactant (a medicine that helps lungs work) to premature babies born between 27 and 35 weeks of pregnancy. It aims to reduce the need for more breathing support and avoid side effects.
This study compares two ways of giving surfactant (a lung-coating medicine) to newborns with breathing trouble: LISA (a gentler, less invasive method) versus traditional breathing tube delivery. Researchers will use ultrasound to see how the medicine spreads in each baby's lungs to find the best approach.
This trial tests a less invasive way to give surfactant (a lung treatment) to babies born a few weeks early who need breathing help. It aims to see if this method works as well as standard care.
This study tests whether giving surfactant medication guided by a lung ultrasound, instead of by X-ray, helps preterm babies with breathing problems get better without needing a breathing tube. Babies in the study receive surfactant through a thin tube while still on non-invasive breathing support.
This trial tests if giving surfactant (a natural substance that helps lungs stay open) through a special airway device can help late preterm and early term infants with breathing problems. The goal is to see if this approach works better than current methods without needing a breathing tube.
Hear when a new Early Administration of Pulmonary Surfactant Guided by Lung Ultrasound Scores in Very Preterm Infants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.